Stefanova et al., 2014 - Google Patents
Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer diseaseStefanova et al., 2014
View PDF- Document ID
- 7266211496344273725
- Author
- Stefanova N
- Kozhevnikova O
- Vitovtov A
- Maksimova K
- Logvinov S
- Rudnitskaya E
- Korbolina E
- Muraleva N
- Kolosova N
- Publication year
- Publication venue
- Cell cycle
External Links
Snippet
Senescence-accelerated OXYS rats are an experimental model of accelerated aging that was established from Wistar stock via selection for susceptibility to cataractogenic effects of a galactose-rich diet and via subsequent inbreeding of highly susceptible rats. Currently, we …
- 241000700159 Rattus 0 title abstract description 155
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stefanova et al. | Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease | |
| Querfurth et al. | Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration | |
| Skaper | Alzheimer’s disease and amyloid: culprit or coincidence | |
| Moreira et al. | The key role of mitochondria in Alzheimer's disease | |
| Lashuel et al. | The many faces of α-synuclein: from structure and toxicity to therapeutic target | |
| Xiang et al. | The role of endoplasmic reticulum stress in neurodegenerative disease | |
| Sivak | The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease | |
| C. Stefani et al. | The role of ER stress-induced apoptosis in neurodegeneration | |
| Stefanova et al. | An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology | |
| Ma et al. | Insulin resistance and cognitive dysfunction | |
| Mattson et al. | Ageing and neuronal vulnerability | |
| Ferreira et al. | Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release | |
| Dhawan et al. | Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism | |
| Ho et al. | Tauopathy in the retina and optic nerve: Does it shadow pathological changes in the brain? | |
| Brown | ORGINAL ARTICLE Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence | |
| Jellinger | Parkinson's disease | |
| Muneer et al. | Endoplasmic reticulum stress: implications for neuropsychiatric disorders | |
| Zulfiqar et al. | Contribution of astrocytes to metabolic dysfunction in the Alzheimer’s disease brain | |
| Wang et al. | CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis | |
| Bellato et al. | Translational control by eIF2α in neurons: beyond the stress response | |
| Michalicova et al. | Tauopathies-focus on changes at the neurovascular unit | |
| Norris et al. | Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders | |
| Della Sala et al. | Synaptic plasticity and signaling in Rett syndrome | |
| Amartumur et al. | Neuropathogenesis-on-chips for neurodegenerative diseases | |
| Kim et al. | L-histidine and L-carnosine exert anti-brain aging effects in D-galactose-induced aged neuronal cells |